: Drug Discovery Summit

Drug Discovery Summit

26 - 27 October 2021 | London, UK
22nd Annual
Drug Discovery Summit
26 - 27 October 2021 | London, UK

An invaluable resource for those looking to improve efficiency, increase pipelines and keep up to date with the latest advances. Featuring key insights into protein degradation, AI/ML in drug discovery, and much more

The Drug Discovery Summit features...

Over 400 attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions

A look at the future of drug discovery in new modalities such as protein degradation, RNA based therapeutics and case studies on the identification and Validation of Novel Targets

The latest updates on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling, and novel RNA drug targets

Insights into drug discovery strategies & next generation therapeutics, empowering drug discovery with chemical biology, target validation, drug profiling and protein degradation technologies

An evaluation of the Development of Clinical Biomarker translation and patient engagement

Agenda at a Glance

Day One

Morning Sessions:

Stream 1: Identification and Validating Novel Targets – Case Study Presentations
Stream 2: Phenotypic Based Discovery & Screening Approaches
Stream 3: New Modalities And Challenging Targets: Targeted Protein Degradation and PROTAC

Afternoon Interactive Sessions:

Roundtable Discussions:
– Identification and Validating Novel Targets
– New Modalities And Challenging Targets: Targeted Protein Degradation & PROTAC

Workshops:
– Molecular Glue for New Drug Development Workshop
– E3 Ubiquitin Ligases and Targeted Protein Degradation
– Overview Of Available Methods To Characterize The Compound – Target Interaction On A Molecular Level Via SPR, MST, ITC and TSA

Day Two

Morning Sessions:

Stream 1: New Modalities And Challenging Targets: RNA based Therapeutics
Stream 2: Animal and Disease Modelling, Organoid based Discovery, 3D Media

Afternoon Interactive Sessions:

Roundtable Discussions:
– Target Discovery and Animal Modelling
– Translational Biomarkers and Patient Engagement

Workshop: Development And Identification Of Biomarkers, New Targets And Combination Therapies For Cancer

Live Webinar

Application of In-Vitro and In-Vivo ADME/PK/Expl Tox assays to Support Lead and Candidate Selections

Wednesday, 18th November, 2020
10:00am GMT (UTC+0)

hosted by Lilly Xu, Ph.D. Senior Vice President, DMPK & Exploratory Toxicology Dept, ChemPartner